ATE309804T1 - Foerderung der wundheilung durch chemisch modifizierte tetracycline - Google Patents

Foerderung der wundheilung durch chemisch modifizierte tetracycline

Info

Publication number
ATE309804T1
ATE309804T1 AT97935248T AT97935248T ATE309804T1 AT E309804 T1 ATE309804 T1 AT E309804T1 AT 97935248 T AT97935248 T AT 97935248T AT 97935248 T AT97935248 T AT 97935248T AT E309804 T1 ATE309804 T1 AT E309804T1
Authority
AT
Austria
Prior art keywords
activity
wound healing
capacity
epithelialized tissue
healing
Prior art date
Application number
AT97935248T
Other languages
English (en)
Inventor
Nungavaram S Ramamurthy
Lorne M Golub
Thomas F Mcnamara
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE309804T1 publication Critical patent/ATE309804T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97935248T 1996-08-01 1997-08-01 Foerderung der wundheilung durch chemisch modifizierte tetracycline ATE309804T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/691,135 US5827840A (en) 1996-08-01 1996-08-01 Promotion of wound healing by chemically-modified tetracyclines
PCT/US1997/013534 WO1998005340A1 (en) 1996-08-01 1997-08-01 Promotion of wound healing by chemically-modified tetracyclines

Publications (1)

Publication Number Publication Date
ATE309804T1 true ATE309804T1 (de) 2005-12-15

Family

ID=24775298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97935248T ATE309804T1 (de) 1996-08-01 1997-08-01 Foerderung der wundheilung durch chemisch modifizierte tetracycline

Country Status (11)

Country Link
US (1) US5827840A (de)
EP (1) EP0923378B1 (de)
JP (1) JP2000516214A (de)
KR (1) KR100494206B1 (de)
AT (1) ATE309804T1 (de)
AU (1) AU3823497A (de)
CA (1) CA2261805C (de)
DE (1) DE69734661T2 (de)
DK (1) DK0923378T3 (de)
ES (1) ES2255107T3 (de)
WO (1) WO1998005340A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
MXPA01012169A (es) 1999-05-27 2002-06-21 Euro Celtique Sa Preparaciones para la aplicacion de agentes anti-infecciosos y/o anti-lamatorios para partes externas o internas del cuerpo humano o animal en la remodelacion funcional y cosmetica y tratamientos para reparacion de tejidos.
EP1829546A1 (de) * 1999-09-14 2007-09-05 Mucosal Therapeutics LLC Formulierungen zur Behandlung oder Vorbeugung von Mucositis
EP1212050B1 (de) * 1999-09-14 2006-12-06 Mucosal Therapeutics LLC Zusammensetzungen, welche tetracycline enthalten, zur behandlung oder verhinderung von mukositis
US6946118B1 (en) * 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
WO2001093891A1 (en) * 2000-06-02 2001-12-13 Yu Liu Non-antibacterial tetracycline as anti-fungal agents
EP2311440A1 (de) * 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Gesteuerte Freigabe von Tetracyclinverbindungen und Tetracyclinderivaten
EP1383508B1 (de) * 2001-04-05 2006-06-21 Collagenex Pharmaceuticals, Inc. Doxycyclin zur behandlung von akne
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP2327409A1 (de) 2001-07-13 2011-06-01 Paratek Pharmaceuticals, Inc. Tetracycline Verbindung mit therapeutischer Wirkung
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
US20030083321A1 (en) * 2001-09-25 2003-05-01 Lerner David S. Composition and method for minimizing or avoiding adverse effects of vesicants
AU2002357370A1 (en) * 2001-12-20 2003-07-09 Hartmut M. Hanauske-Abel Treatment for averting or delaying premature delivery
ES2551708T3 (es) 2002-01-08 2015-11-23 Paratek Pharmaceuticals, Inc. Compuestos de 4-desdimetilamino tetraciclina
EP2311451A1 (de) 2002-03-08 2011-04-20 Paratek Pharmaceuticals, Inc. Aminomethyl-substituierte Tetracyclin-Verbindungen
EP1503981A4 (de) 2002-03-21 2007-08-15 Paratek Pharm Innc Substituierte tetracyclinverbindungen
EP1494681A4 (de) * 2002-04-16 2008-08-06 Collagenex Pharm Inc Verfahren zum gleichzeitigen behandeln von okularer rosacea und akne rosacea
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
JP2005526114A (ja) * 2002-05-06 2005-09-02 コッラジェネックス ファーマシューチカルス インコーポレイテッド 粘膜炎及び真菌感染症の同時治療方法
AU2003261161B2 (en) 2002-07-12 2009-09-10 Paratek Pharmaceuticals, Inc 3, 10, and 12a substituted tetracycline compounds
CA2491655A1 (en) * 2002-07-12 2004-01-22 The Research Foundation Of State University Of New York Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
US20080139512A1 (en) * 2002-09-25 2008-06-12 Quick-Med Technologies, Inc. Method for minimizing or avoiding adverse effects of vesicants
WO2004091483A2 (en) 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
AU2004259661B2 (en) 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20050143352A1 (en) 2003-07-09 2005-06-30 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP1684768A4 (de) * 2003-11-06 2007-06-06 Univ New York State Res Found Verfahren zur behandlung von ekzem
JP5010284B2 (ja) * 2004-01-15 2012-08-29 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物の芳香族ａ環誘導体
EP1805134B1 (de) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracycline und verfahren zu ihrer verwendung
EP2033950A1 (de) 2004-10-25 2009-03-11 Paratek Pharmaceuticals, Inc. Substituierte Tetracyclin-Verbindungen
US20060252731A1 (en) * 2005-05-06 2006-11-09 Pfeiffer David F Methods of treating recurrent aphthous stomatitis
US20070093455A1 (en) * 2005-07-21 2007-04-26 Paul Abato 10-substituted tetracyclines and methods of use thereof
CA2892739A1 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
WO2008079339A2 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
EP2216323A3 (de) * 2007-04-27 2010-12-29 Paratek Pharmaceuticals, Inc. Verfahren zur Synthetisierung und Reinigung von Aminoalkyl-Tetracyclinverbindungen
EP2176216B1 (de) * 2007-07-06 2012-04-25 Paratek Pharmaceuticals, Inc. Verfahren zur synthese von 9-substituiertem minocyclin
TWI680117B (zh) 2008-05-19 2019-12-21 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
KR101746795B1 (ko) 2008-08-08 2017-06-13 테트라페이즈 파마슈티컬스, 인코포레이티드 Ｃ７-플루오로 치환된 테트라시클린 화합물
WO2010129057A2 (en) 2009-05-08 2010-11-11 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
NO2470500T3 (de) 2009-08-28 2018-03-03
DK2552890T3 (en) 2010-03-31 2017-04-03 Tetraphase Pharmaceuticals Inc POLYCYCLIC TETRACYCLINE COMPOUNDS
CA2883238C (en) 2012-08-31 2021-11-23 Tetraphase Pharmaceuticals, Inc. Tetracycline compounds
CN104307031B (zh) * 2014-11-10 2015-12-30 刘维峰 一种皮肤外用修复材料的制备方法及用途
HUE066360T2 (hu) 2016-10-19 2024-07-28 Tetraphase Pharmaceuticals Inc Eravaciklin kristályformái
US12570604B2 (en) 2018-11-09 2026-03-10 Tetraphase Pharmaceuticals, Inc. Polymorphic forms of a tetracycline compound and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767900U (de) * 1958-03-27 1958-06-04 Herbert Dipl Ing Fritzsche Hand- oder taschenleuchte mit blinker.
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US4016877A (en) * 1976-02-23 1977-04-12 Avicon, Inc. Fibrous collagen derived web having hemostatic and wound sealing properties
US4294241A (en) * 1977-06-09 1981-10-13 Teruo Miyata Collagen skin dressing
US4130555A (en) * 1977-09-06 1978-12-19 Nippi Incorporated Peptide mixtures derived from collagenous material or gelatin
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4440680A (en) * 1980-09-24 1984-04-03 Seton Company Macromolecular biologically active collagen articles
DE3037513C2 (de) * 1980-10-03 1983-05-05 Steffan, Wolfgang, 8425 Neustadt Kollagene Wundauflage
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4935412A (en) * 1983-12-29 1990-06-19 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
US4925833A (en) * 1983-12-29 1990-05-15 The Research Foundation Of State University Of New York Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis
US4837024A (en) * 1984-02-24 1989-06-06 The Regents Of The University Of California Compositions, articles and mehtod for improving wound healing
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
US5196196A (en) * 1986-06-03 1993-03-23 Incyte Pharmaceuticals, Inc. Use of protease nexin-I in wound dressings
US4813942A (en) * 1987-03-17 1989-03-21 Bioderm, Inc. Three step wound treatment method and dressing therefor
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
US5227168A (en) * 1989-11-21 1993-07-13 Bruce Barber Method of treating a wound
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
JP3016587B2 (ja) * 1989-12-04 2000-03-06 ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク 非ステロイド抗炎症剤及びテトラサイクリンの配合
GB9000846D0 (en) * 1990-01-15 1990-03-14 Beecham Group Plc Novel compounds
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
US5081106A (en) * 1990-07-16 1992-01-14 The Oregon Health Sciences University Wound dressing protocol utilizing collagen gelatin formed with iodine
US5156601A (en) * 1991-03-20 1992-10-20 Hydromer, Inc. Tacky, hydrophilic gel dressings and products therefrom
US5229380A (en) * 1991-06-28 1993-07-20 Harris Richard Y Method for treating helicobacter pylori gastritis
US5258371A (en) * 1992-05-29 1993-11-02 Kuraray Co., Ltd. Method to reduce connective tissue destruction
DK0599397T3 (da) * 1992-11-17 1996-09-16 Univ New York State Res Found Tetracycliner, herunder non-mikrobielle, kemisk-modificerede tetracycliner, inhiberer overdreven collagentværbinding ved diabetes

Also Published As

Publication number Publication date
EP0923378A1 (de) 1999-06-23
CA2261805C (en) 2008-11-04
DK0923378T3 (da) 2006-04-03
EP0923378B1 (de) 2005-11-16
EP0923378A4 (de) 2000-11-15
WO1998005340A1 (en) 1998-02-12
KR20000029753A (ko) 2000-05-25
JP2000516214A (ja) 2000-12-05
AU3823497A (en) 1998-02-25
DE69734661D1 (de) 2005-12-22
ES2255107T3 (es) 2006-06-16
US5827840A (en) 1998-10-27
KR100494206B1 (ko) 2005-06-13
DE69734661T2 (de) 2006-08-10
CA2261805A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
ATE309804T1 (de) Foerderung der wundheilung durch chemisch modifizierte tetracycline
DK0489032T3 (da) Hydroxaminsyre-baserede kollagenaseinhibitorer
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
ES2155135T3 (es) Aposito en forma de gel para heridas.
DK1227820T3 (da) Oligosaccharidaldonsyrer og topisk anvendelse deraf
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
DE69634430D1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
RU2007118663A (ru) Способ применения адапалена при поддерживающей терапии угревой сыпи
ATE474572T1 (de) Heilung von wunden
EP1404412A4 (de) Behandlung und zusammensetzung für die wundheilung
DE69716460D1 (de) Wundheilung und behandlung von fibrose
ATE335501T1 (de) Mittel zur behandlung von allergischen oder überempfindlichkeitszuständen
TW460295B (en) Topical pharmaceutical compositions comprising bismuth subgallate and borneol for wound healing and preventing scarring and granulation
ATE471985T1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
ATE255426T1 (de) Dermales hüllgewebe in der wundheilung
DE68919009D1 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
DK0951294T3 (da) Sårhelende formuleringer indeholdende humanplasmafibronectin
ATE226089T1 (de) Verwendung einer zubereitung enthaltend einen plasminogen-aktivator für die verbesserung der wundheilung
KR101987332B1 (ko) 여드름 피부 완화 얼굴마스크
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
MY143194A (en) Topical pharmaceutical compositions for healing wounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0923378

Country of ref document: EP